Stenoparib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Stenoparib, covering 2026-03-11 to 2026-03-11. Get the full timeline:
Most recent: Clinical Trial Update: Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC [Phase 1, Phase 2]